Shortening the biologics clinical timeline with a novel method for generating stable, high‐producing cell pools and clones
Biotechnology and Bioengineering · 2025
DOI: 10.1002/bit.28323 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biotechnology and Bioengineering, 2025. Verfasst von Chad A Hall und 10 weiteren Autor:innen. Beteiligte Einrichtung: Catalent Pharma Solutions, Somerset, New Jersey, USA. Hauptthemen laut MEDLINE: Biological Products. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 17 Literaturangaben.
Abstract (Originalsprache)
Reducing drug development timelines is an industry‐wide goal to bring medicines to patients in need more quickly. This was exemplified in the coronavirus disease 2019 pandemic where reducing development timelines had a direct impact on the number of lives lost to the disease. The use of drug substances produced using cell pools, as opposed to clones, has the potential to shorten development timelines. Toward this goal, we have developed a novel technology, GPEx® Lightning, that allows for rapid, reproducible, targeted recombination of transgenes into more than 200 Dock sites in the Chinese hamster ovary cell line genome. This allows for rapid production of high‐expressing stable cell pools and clones that reach titers of 4–12 g/l in generic fed‐batch production. These pools and clones are highly stable in both titer and glycosylation, showing strong similarities in glycosylation profiles.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Catalent Pharma Solutions, Somerset, New Jersey, USA.
Zitieren
APA
Hall, C. A., Kravitz, R. H., Johnson, K. F., Sanek, N. A., Maiti, P., Ziemba, K. R., Liu, J., Andreev, D. O., Chrostowski, V. L., Collins, I. J., & Bleck, G. T. (2025). Shortening the biologics clinical timeline with a novel method for generating stable, high‐producing cell pools and clones. Biotechnology and Bioengineering. https://doi.org/10.1002/bit.28323
Vancouver
Hall CA, Kravitz RH, Johnson KF, Sanek NA, Maiti P, Ziemba KR, et al. Shortening the biologics clinical timeline with a novel method for generating stable, high‐producing cell pools and clones. Biotechnology and Bioengineering. 2025. doi:10.1002/bit.28323
BibTeX
@article{Hall2025,
author = {Hall, Chad A and Kravitz, Rachel H and Johnson, Karl F and Sanek, Nicholas A and Maiti, Payel and Ziemba, Keith R and Liu, Jia and Andreev, Dmitri O and Chrostowski, Victoria L and Collins, Ian J and Bleck, Gregory T},
title = {Shortening the biologics clinical timeline with a novel method for generating stable, high‐producing cell pools and clones},
journal = {Biotechnology and Bioengineering},
year = {2025},
doi = {10.1002/bit.28323}
}
EUVIMED